23andMe Holding Co. (ME)

USD 0.61

(0.0%)

Net Debt Summary of 23andMe Holding Co.

  • 23andMe Holding Co.'s latest annual net debt in 2023 was -141.37 Million USD , up 53.12% from previous year.
  • 23andMe Holding Co.'s latest quarterly net debt in 2024 Q1 was -97.3 Million USD , up 32.23% from previous quarter.
  • 23andMe Holding Co. reported annual net debt of -301.54 Million USD in 2022, up 35.41% from previous year.
  • 23andMe Holding Co. reported annual net debt of -466.87 Million USD in 2021, down -147.33% from previous year.
  • 23andMe Holding Co. reported quarterly net debt of -175.33 Million USD for 2023 Q2, up 24.13% from previous quarter.
  • 23andMe Holding Co. reported quarterly net debt of -231.11 Million USD for 2023 Q1, up 23.36% from previous quarter.

Annual Net Debt Chart of 23andMe Holding Co. (2023 - 2018)

Historical Annual Net Debt of 23andMe Holding Co. (2023 - 2018)

Year Net Debt Net Debt Growth
2023 -141.37 Million USD 53.12%
2022 -301.54 Million USD 35.41%
2021 -466.87 Million USD -147.33%
2020 -188.76 Million USD -58.6%
2019 -119.01 Million USD 64.74%
2018 -337.56 Million USD 0.0%

Peer Net Debt Comparison of 23andMe Holding Co.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD -258.339%
Applied DNA Sciences, Inc. -5.91 Million USD -2290.447%
Aspira Women's Health Inc. -331 Thousand USD -42610.574%
Biodesix, Inc. 34.3 Million USD 512.079%
BioNexus Gene Lab Corp. -5.79 Million USD -2339.155%
bioAffinity Technologies, Inc. -1.24 Million USD -11274.083%
bioAffinity Technologies, Inc. -1.24 Million USD -11274.083%
Bionano Genomics, Inc. 34.88 Million USD 505.286%
CareDx, Inc -47.97 Million USD -194.672%
Check-Cap Ltd. -24.75 Million USD -471.062%
Castle Biosciences, Inc. -83.53 Million USD -69.245%
DarioHealth Corp. -7.54 Million USD -1772.973%
Exact Sciences Corporation 1.94 Billion USD 107.252%
Fulgent Genetics, Inc. -82.56 Million USD -71.223%
Guardant Health, Inc. 220.22 Million USD 164.194%
ICON Public Limited Company 3.56 Billion USD 103.971%
IDEXX Laboratories, Inc. 493.94 Million USD 128.621%
Illumina, Inc. 1.21 Billion USD 111.645%
Intelligent Bio Solutions Inc. -5.43 Million USD -2502.262%
iSpecimen Inc. -2.14 Million USD -6483.336%
Standard BioTools Inc. 46.5 Million USD 403.987%
MDxHealth SA 18.88 Million USD 848.594%
Medpace Holdings, Inc. -103.32 Million USD -36.82%
Myriad Genetics, Inc. 88.1 Million USD 260.468%
Mainz Biomed B.V. 349.85 Thousand USD 40508.741%
ENDRA Life Sciences Inc. -2.43 Million USD -5695.112%
NeoGenomics, Inc. 269.19 Million USD 152.517%
Neogen Corporation 735.62 Million USD 119.218%
Inotiv, Inc. 382.14 Million USD 136.994%
Natera, Inc. -200.1 Million USD 29.35%
OpGen, Inc. 11.89 Million USD 1288.811%
OPKO Health, Inc. 230.68 Million USD 161.284%
Psychemedics Corporation 334 Thousand USD 42426.946%
Prenetics Global Limited -43.33 Million USD -226.215%
Prenetics Global Limited -43.33 Million USD -226.215%
Precipio, Inc. -386 Thousand USD -36524.87%
Personalis, Inc. -8.02 Million USD -1662.304%
RadNet, Inc. 1.14 Billion USD 112.309%
Sera Prognostics, Inc. -2.02 Million USD -6891.691%
Sotera Health Company 2.02 Billion USD 106.98%
Neuronetics, Inc. 2.79 Million USD 5154.415%
Star Equity Holdings, Inc. -15.33 Million USD -821.771%
Star Equity Holdings, Inc. -15.33 Million USD -821.771%
Trinity Biotech plc 63.73 Million USD 321.809%
T2 Biosystems, Inc. 33.8 Million USD 518.149%
Twist Bioscience Corporation -192.4 Million USD 26.522%
Exagen Inc. -12.77 Million USD -1006.89%